The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(4-((4-(1H-Pyrazol-4-yl)phenyl)amino)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)phenoxy)-N-phenylacetamide ID: ALA4649877
PubChem CID: 124159207
Max Phase: Preclinical
Molecular Formula: C29H24N6O3
Molecular Weight: 504.55
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(COc1cccc(-c2nc3c(c(Nc4ccc(-c5cn[nH]c5)cc4)n2)COC3)c1)Nc1ccccc1
Standard InChI: InChI=1S/C29H24N6O3/c36-27(32-22-6-2-1-3-7-22)18-38-24-8-4-5-20(13-24)28-34-26-17-37-16-25(26)29(35-28)33-23-11-9-19(10-12-23)21-14-30-31-15-21/h1-15H,16-18H2,(H,30,31)(H,32,36)(H,33,34,35)
Standard InChI Key: VNVXWWIVHYSSSO-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
15.7781 -16.7881 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4919 -16.3745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4891 -15.5478 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7763 -15.1425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7739 -14.3212 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4845 -13.9064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1955 -14.3193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9056 -13.9052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9036 -13.0830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1856 -12.6767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4783 -13.0891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6040 -12.6730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3561 -13.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9044 -12.3883 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4927 -11.6782 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6900 -11.8558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2009 -16.7854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2008 -17.6078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9125 -18.0152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6205 -17.6055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6166 -16.7799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9085 -16.3721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3263 -16.3636 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0402 -16.7727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7500 -16.3564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7458 -15.5351 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4639 -16.7655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1736 -16.3492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0659 -16.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0626 -15.5544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2809 -15.3052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8036 -15.9719 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2863 -16.6304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8865 -16.7599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5957 -16.3443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5905 -15.5206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8701 -15.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1638 -15.5322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 30 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 12 2 0
9 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
2 17 1 0
21 23 1 0
23 24 1 0
24 25 1 0
25 26 2 0
25 27 1 0
27 28 1 0
29 30 2 0
30 31 1 0
31 32 1 0
32 33 1 0
33 29 1 0
28 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 504.55Molecular Weight (Monoisotopic): 504.1910AlogP: 5.33#Rotatable Bonds: 8Polar Surface Area: 114.05Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.57CX Basic pKa: 4.00CX LogP: 4.83CX LogD: 4.83Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -1.56
References 1. Liu KG, Kim JI, Olszewski K, Barsotti AM, Morris K, Lamarque C, Yu X, Gaffney J, Feng XJ, Patel JP, Poyurovsky MV.. (2020) Discovery and Optimization of Glucose Uptake Inhibitors., 63 (10): [PMID:32282207 ] [10.1021/acs.jmedchem.9b02153 ]